| pubmed-article:10718823 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10718823 | lifeskim:mentions | umls-concept:C0040160 | lld:lifeskim |
| pubmed-article:10718823 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:10718823 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:10718823 | lifeskim:mentions | umls-concept:C0339143 | lld:lifeskim |
| pubmed-article:10718823 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:10718823 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:10718823 | lifeskim:mentions | umls-concept:C2348519 | lld:lifeskim |
| pubmed-article:10718823 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:10718823 | pubmed:dateCreated | 2000-5-15 | lld:pubmed |
| pubmed-article:10718823 | pubmed:abstractText | Graves' ophthalmopathy (GO) and Graves' hyperthyroidism are closely associated diseases and thought to be caused by the same autoimmune process. An obvious explanation for this would be the presence of autoantibodies reacting with an autoantigen present in the orbit and the thyroid gland. The TSH-Receptor (TSH-R) antibodies are a likely candidate, because they cause Graves' hyperthyroidism and the TSH-R appears to be present also in orbital tissues. If TSH-R antibodies are responsible for the ophthalmopathy one would expect their titres to correlate with clinical characteristics of the eye disease. The aim of the present study is to see whether TSH-R antibodies are related to the activity and severity of the thyroid-associated ophthalmopathy. | lld:pubmed |
| pubmed-article:10718823 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10718823 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10718823 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10718823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10718823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10718823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10718823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10718823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10718823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10718823 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10718823 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:10718823 | pubmed:issn | 0300-0664 | lld:pubmed |
| pubmed-article:10718823 | pubmed:author | pubmed-author:van der... | lld:pubmed |
| pubmed-article:10718823 | pubmed:author | pubmed-author:WiersingaW... | lld:pubmed |
| pubmed-article:10718823 | pubmed:author | pubmed-author:PrummelM FMF | lld:pubmed |
| pubmed-article:10718823 | pubmed:author | pubmed-author:BakkerOO | lld:pubmed |
| pubmed-article:10718823 | pubmed:author | pubmed-author:BroeninkMM | lld:pubmed |
| pubmed-article:10718823 | pubmed:author | pubmed-author:GerdingM NMN | lld:pubmed |
| pubmed-article:10718823 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10718823 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:10718823 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10718823 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10718823 | pubmed:pagination | 267-71 | lld:pubmed |
| pubmed-article:10718823 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
| pubmed-article:10718823 | pubmed:meshHeading | pubmed-meshheading:10718823... | lld:pubmed |
| pubmed-article:10718823 | pubmed:meshHeading | pubmed-meshheading:10718823... | lld:pubmed |
| pubmed-article:10718823 | pubmed:meshHeading | pubmed-meshheading:10718823... | lld:pubmed |
| pubmed-article:10718823 | pubmed:meshHeading | pubmed-meshheading:10718823... | lld:pubmed |
| pubmed-article:10718823 | pubmed:meshHeading | pubmed-meshheading:10718823... | lld:pubmed |
| pubmed-article:10718823 | pubmed:meshHeading | pubmed-meshheading:10718823... | lld:pubmed |
| pubmed-article:10718823 | pubmed:meshHeading | pubmed-meshheading:10718823... | lld:pubmed |
| pubmed-article:10718823 | pubmed:meshHeading | pubmed-meshheading:10718823... | lld:pubmed |
| pubmed-article:10718823 | pubmed:meshHeading | pubmed-meshheading:10718823... | lld:pubmed |
| pubmed-article:10718823 | pubmed:meshHeading | pubmed-meshheading:10718823... | lld:pubmed |
| pubmed-article:10718823 | pubmed:meshHeading | pubmed-meshheading:10718823... | lld:pubmed |
| pubmed-article:10718823 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10718823 | pubmed:articleTitle | Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. | lld:pubmed |
| pubmed-article:10718823 | pubmed:affiliation | Department of Endocrinology and Metabolism, Academic Medical Centre, Amsterdam, The Netherlands. | lld:pubmed |
| pubmed-article:10718823 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10718823 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10718823 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10718823 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10718823 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10718823 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10718823 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10718823 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10718823 | lld:pubmed |
